Shares of Los Angeles-area biotech firm Xencor Inc. soared Tuesday by 32% after the company announced a deal with Swiss drug giant Novartis.
Under the agreement, Novartis will pay Xencor $150 million now and potentially much more in the future as the companies work to develop and commercialize two experimental cancer drugs.
15:00 Preview: Dan Straily starts for Marlins, aims to quiet Dodgers21
20:32 Colts sign third-round pick Basham to complete rookie class14
17:09 Behold, the tale of a fan who says an errant Tebow throw konked him in the biscuits41
22:46 Cupp: Democrats will definitely turn on Mueller39